ALLIANCE-A052101
Phase III
OPEN TO ACCRUAL
A Randomized Phase 3 Trial of Continuous vs. Intermittent Maintenance Therapy with Zanubrutinib as Upfront Treatment in Older Patients with Mantle Cell Lymphoma
SWOG-S2308
Phase III
OPEN TO ACCRUAL
Randomized Phase III Study of Mosunetuzumab vs. Rituximab for Low Tumor Burden Follicular Lymphoma